To include your compound in the COVID-19 Resource Center, submit it here.

Subcutaneous elamipretide: Phase II started

Stealth began the double-blind, placebo-controlled, European Phase II PROGRESS-HF trial to

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE